Low-Volume Cardioplegia and Myocardial Protection in Coronary Artery Bypass Graft Surgery.
Thorac Cardiovasc Surg
; 67(6): 484-487, 2019 Sep.
Article
in En
| MEDLINE
| ID: mdl-30071564
ABSTRACT
We studied myocardial protection during coronary artery bypass graft surgery using low-volume cardioplegia (Cardioplexol) and minimal extracorporeal circulation (MECC) for different types of coronary artery diseases. In total, 426 consecutive patients were included and divided into four groups those with left main stem stenosis (n = 45), those with three-vessel disease (n = 200), those with both (n = 141), and those with neither (n = 40). The peak postoperative myocardial markers and 30-day mortality were analyzed. Both myocardial markers and 30-day mortality were significantly elevated in patients with isolated main stem stenosis. We conclude that the use of low-volume cardioplegia and MECC is safe. However, patients with underlying isolated left main stem stenosis might be less protected.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cardioplegic Solutions
/
Myocardial Reperfusion Injury
/
Coronary Artery Bypass
/
Potassium Compounds
/
Coronary Stenosis
/
Extracorporeal Circulation
/
Heart Arrest, Induced
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Thorac Cardiovasc Surg
Year:
2019
Document type:
Article
Affiliation country:
Switzerland
Publication country:
ALEMANHA
/
ALEMANIA
/
DE
/
DEUSTCHLAND
/
GERMANY